Výsledky vyhledávání - "P. Katsimpri"

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Combined – whole blood and skin fibroblasts- transcriptomic analysis in Psoriatic Arthritis reveals molecular signatures of activity, resistance and early response to treatment

Autor: Alexandros Grivas, Maria Grigoriou, Nikos Malissovas, George Sentis, Anastasia Filia, Sofia Flouda, Pelagia Katsimpri, Panayotis Verginis, Dimitrios T. Boumpas

Publikováno v: Frontiers in Immunology, Vol 13 (2022)

BackgroundAn interplay between immune cells and resident skin and joint stromal cells is implicated in psoriatic arthritis (PsA), yet the mechanisms remain elusive with a paucity of molecular biomarkers for activity and response. Combined transcripto

Externí odkaz: https://doaj.org/article/36aa5a270ecb4844ace766f562ad66e0

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

POS1053 LONG-TERM RETENTION, EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: RESULTS FROM THE OBSERVATIONAL SERENA STUDY

Autor: U. Kiltz, P. Sfikakis, N. Gullick, P. Katsimpri, A. Kotrotsios, J. Brandt-Juergens, E. Lespessailles, N. Maiden, K. Gaffney, D. Peterlik, B. Schulz, E. Pournara, P. Jagiello

Publikováno v: Annals of the Rheumatic Diseases. 81:846-847

BackgroundSERENA is an ongoing, longitudinal, observational study of more than 2900 patients (pts) with moderate to severe psoriasis, active psoriatic arthritis (PsA), and ankylosing spondylitis (AS) conducted at 438 sites across Europe with an expec

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::66f7606fbad13c88beb1eb1a19ec39ce
https://doi.org/10.1136/annrheumdis-2022-eular.2673

Zobrazit plný text záznamu

POS0368 EARLY (3 MONTHS) IMPROVEMENT IN PHYSICIAN GLOBAL ASSESSMENT OF DISEASE ACTIVITY PREDICTS LONG-TERM RETENTION OF BELIMUMAB TREATMENT IN SLE: A MULTICENTRE OBSERVATIONAL STUDY OF 184 PATIENTS

Autor: M. Nikoloudaki, D. Nikolopoulos, S. Koutsoviti, I. Flouri, N. Kapsala, A. Repa, P. Katsimpri, E. Theotikos, S. Pitsigavdaki, K. Pateromichelaki, A. Eskitzis, A. Elezoglou, P. Sidiropoulos, A. Fanouriakis, D. Boumpas, G. Bertsias

Publikováno v: Annals of the Rheumatic Diseases. 81:437-438

BackgroundBelimumab has been introduced in the management of SLE for more than 10 years, however long-term efficacy and safety data are still limited and mostly derive from the extended phase of randomized clinical trials.ObjectivesTo evaluate the lo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::4d7c27bb42e66965611cea73fec8f20c
https://doi.org/10.1136/annrheumdis-2022-eular.4735

Zobrazit plný text záznamu

POS0210 A PREDOMINANT NON-SPECIFIC INTERSTITIAL PNEUMONIA PATTERN AND ABERRANT TRANSCRIPTOMIC NEUTROPHIL-MEDIATED IMMUNITY CHARACTERIZE A CONTEMPORARY RA-ILD COHORT

Autor: S. Flouda, A. Grivas, N. Kapsala, M. Grigoriou, D. Nikolopoulos, A. Filia, G. Sentis, K. Chavatza, M. Aggelakos, G. S. Moysidou, M. Kosmetatou, D. Tseronis, P. Katsimpri, T. Karageorgas, A. Fanouriakis, D. Boumpas

Publikováno v: Annals of the Rheumatic Diseases. 81:341.1-341

BackgroundLung involvement is the most common extra-articular manifestation. Rheumatoid arthritis related interstitial lung disease (RA-ILD) comprises a heterogeneous group of parenchymal lung disorders classified by distinct clinical, pathologic, an

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::3a85208622d66477f14537692903e9a3
https://doi.org/10.1136/annrheumdis-2022-eular.3502

Zobrazit plný text záznamu

POS0326 THE ΤRANSCRIPTOMIC LANDSCAPE OF ACTIVE PSORIATIC ΑRTHRITIS: ACTIVATED INNATE ΙMMUNITY, EXTRACELLULAR MATRIX (ECM) TURNOVER, ABERRANT METABOLISM AND HEMOPOIETIC CELL - SKIN CROSSTALK

Autor: A. Grivas, M. Grigoriou, G. Sentis, A. Filia, P. Katsimpri, P. Verginis, D. Boumpas

Publikováno v: Annals of the Rheumatic Diseases. 81:414.2-414

BackgroundPsoriatic arthritis (PsA) is a chronic inflammatory disease whereby activated T lymphocytes and myeloid cells interact with tissue-resident cells in the skin and joints. Gene expression studies, mainly based on the microarray platforms, hav

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::2b83add70835ba0a5991986de704499c
https://doi.org/10.1136/annrheumdis-2022-eular.3202

Zobrazit plný text záznamu

POS0365 RELAPSES ARE COMMON ΙΝ SEVERE HEMATOLOGICAL SLE: REAL-LIFE EXPERIENCE FROM THE 'ATTIKON' LUPUS COHORT

Autor: G. S. Moysidou, S. Flouda, M. Kosmetatou, N. Kapsala, D. Tseronis, M. Aggelakos, T. Karageorgas, D. Nikolopoulos, K. Chavatza, A. Filippopoulou, K. Zoupidou, P. Katsimpri, A. Fanouriakis, D. Boumpas

Publikováno v: Annals of the Rheumatic Diseases. 81:435.2-436

BackgroundHematological manifestations are common in systemic lupus erythematosus (SLE), and are thought to result from immune-mediated peripheral cell destruction or bone marrow failure(1,2).ObjectivesTo assess the clinical characteristics and outco

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::a76c85d57808aab941c4583ad6d85c6f
https://doi.org/10.1136/annrheumdis-2022-eular.4900

Zobrazit plný text záznamu

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Akademický článek

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Vyhledávací nástroje:

Upřesnit hledání